Amdocs Ltd. (DOX) Position Raised by ClariVest Asset Management LLC
ClariVest Asset Management LLC boosted its stake in shares of Amdocs Ltd. (NASDAQ:DOX) by 0.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 261,231 shares of the company’s stock after buying an additional 287 shares during the period. ClariVest Asset Management LLC owned approximately 0.17% of Amdocs worth $15,079,000 at the end of the most recent reporting period.
Other institutional investors have also recently modified their holdings of the company. BB&T Securities LLC increased its position in shares of Amdocs by 4.4% in the first quarter. BB&T Securities LLC now owns 53,252 shares of the company’s stock worth $3,217,000 after buying an additional 2,238 shares in the last quarter. Willis Investment Counsel increased its position in shares of Amdocs by 2.5% in the first quarter. Willis Investment Counsel now owns 149,075 shares of the company’s stock worth $9,007,000 after buying an additional 3,685 shares in the last quarter. Credit Agricole S A increased its position in shares of Amdocs by 542.4% in the first quarter. Credit Agricole S A now owns 150,224 shares of the company’s stock worth $9,077,000 after buying an additional 126,840 shares in the last quarter. Investec Asset Management North America Inc. increased its position in shares of Amdocs by 4.6% in the first quarter. Investec Asset Management North America Inc. now owns 200,198 shares of the company’s stock worth $12,096,000 after buying an additional 8,715 shares in the last quarter. Finally, Investec Asset Management LTD increased its position in shares of Amdocs by 4.8% in the first quarter. Investec Asset Management LTD now owns 3,269,460 shares of the company’s stock worth $197,541,000 after buying an additional 150,828 shares in the last quarter. 89.63% of the stock is owned by hedge funds and other institutional investors.
Shares of Amdocs Ltd. (NASDAQ:DOX) traded up 1.53% during midday trading on Thursday, reaching $59.57. 1,051,758 shares of the company traded hands. The company has a market capitalization of $8.87 billion, a PE ratio of 22.52 and a beta of 0.73. Amdocs Ltd. has a 1-year low of $50.06 and a 1-year high of $61.33. The company has a 50 day moving average price of $59.36 and a 200 day moving average price of $58.22.
Amdocs (NASDAQ:DOX) last posted its quarterly earnings data on Tuesday, July 26th. The company reported $0.90 EPS for the quarter, topping the consensus estimate of $0.87 by $0.03. The firm earned $930 million during the quarter, compared to analyst estimates of $928.81 million. Amdocs had a net margin of 10.93% and a return on equity of 14.59%. Amdocs’s revenue was up 2.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.84 EPS. On average, analysts expect that Amdocs Ltd. will post $3.58 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 21st. Investors of record on Friday, September 30th will be paid a dividend of $0.195 per share. The ex-dividend date is Wednesday, September 28th. This represents a $0.78 annualized dividend and a dividend yield of 1.31%. Amdocs’s dividend payout ratio (DPR) is presently 29.32%.
A number of equities analysts have weighed in on DOX shares. Citigroup Inc. raised their target price on shares of Amdocs from $63.00 to $66.00 and gave the company a “buy” rating in a research note on Wednesday, July 27th. JPMorgan Chase & Co. raised their target price on shares of Amdocs from $61.00 to $64.00 and gave the company a “neutral” rating in a research note on Wednesday, July 27th. Jefferies Group raised their target price on shares of Amdocs from $56.00 to $58.00 and gave the company a “hold” rating in a research note on Wednesday, July 27th. Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and set a $65.00 target price on shares of Amdocs in a research note on Thursday, September 15th. Finally, Zacks Investment Research raised shares of Amdocs from a “hold” rating to a “buy” rating and set a $64.00 target price for the company in a research note on Tuesday, July 5th. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $63.13.
Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.
Receive News & Stock Ratings for Amdocs Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs Ltd. and related stocks with our FREE daily email newsletter.